Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.51 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 3/20 | 0.48 |
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | HTR1B | P28222 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31323022 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL2805693 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL2024341 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL2028353 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL5357930 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL11324211 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL1826963 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL17702569 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL22166729 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL31275248 | 1.00 | CETP (0.58) | CETPSMN1; SMN2NPC1LMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9677111-B2 | Method of detecting a Salmonella microorganism | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-06-13 | — | — | US | claimed |
| CN-101535496-B | Genetically engineered biological indicator | AMERICAN STERILIZER CO. (US) | 2015-12-02 | — | — | CN | claimed |
| US-20140356888-A1 | METHOD OF DETECTING A SALMONELLA MICROORGANISM | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2014-12-04 | — | — | US | claimed |
| EP-2798075-A1 | METHOD OF DETECTING A SALMONELLA MICROORGANISM | 3M Innovative Properties Company (US) | 2014-11-05 | — | — | EP | claimed |
| CN-104105795-A | Method of detecting a salmonella microorganism | 3M INNOVATIVE PROPERTIES CO | 2014-10-15 | — | — | CN | claimed |
| WO-2013101530-A1 | METHOD OF DETECTING A SALMONELLA MICROORGANISM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-07-04 | — | — | WO | claimed |
| CN-101535496-A | Genetically engineered biological indicator | AMERICAN STERILIZER CO (US) | 2009-09-16 | — | — | CN | claimed |
| US-12564613-B2 | Strains having effects of preventing or treating cancers | GENOME AND COMPANY (KR) | 2026-03-03 | — | — | US | disclosed |
| EP-3897156-B1 | MICROBACTERIUM ESTERAROMATICUM STRAIN, COMPOSITION COMPRISING THE SAME, AND USES THEREOF | FUTURECO BIOSCIENCE S A (ES) | 2025-07-09 | — | — | EP | disclosed |
| US-12214004-B2 | Strains having effects of preventing or treating cancers | GENOME AND COMPANY (KR) | 2025-02-04 | — | — | US | disclosed |
| US-20230115696-A1 | BACTERIAL GENES AND ISOLATES FOR CONFERRING INSECT RESISTANCE | EVOGENE LTD. (IL) | 2023-04-13 | — | — | US | disclosed |
| US-11466247-B2 | Bacterial genes and isolates for conferring insect resistance | EVOGENE LTD. (IL) | 2022-10-11 | — | — | US | disclosed |
| US-20220132862-A1 | PSEUDOMONAS SP. STRAIN, COMPOSITION COMPRISING THE SAME, AND USES THEREOF | FUTURECO BIOSCIENCE, S.A. (ES) | 2022-05-05 | — | — | US | disclosed |
| EP-0457735-A1 | Biocatalytic process for the production of L-(-)-carnitine from crotonobetaine and strains of Proteeae for use in said process | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1991-11-21 | — | — | EP | disclosed |
| EP-0254000-B1 | RAPID DETECTION OF N. GONORRHOEAE WITHOUT CULTURE | MILES INC. (US) | 1991-05-22 | — | — | EP | disclosed |
| EP-0163748-B1 | MANUFACTURE OF HIGHER ARYL ESTERS | Ashland Oil, Inc. (US) | 1988-04-13 | — | — | EP | disclosed |
| EP-0254000-A1 | Rapid detection of N. gonorrhoeae without culture | MILES INC. (US) | 1988-01-27 | — | — | EP | disclosed |
| EP-0163748-A1 | Manufacture of higher aryl esters | Ashland Oil, Inc. (US) | 1985-12-11 | — | — | EP | disclosed |
| US-4477385-A | Manufacture of higher aryl esters | ASHLAND OIL, INC. (US) | 1984-10-16 | — | — | US | disclosed |
| US-4456555-A | Manufacture of aryl esters | ASHLAND OIL, INC. (US) | 1984-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12214004-B2 | Strains having effects of preventing or treating cancers | LGALS3, B3GAT3, MKI67 | CETP 1936/4885SMN1; SMN2 2782/4885NPC1 2956/4885 |
| US-12564613-B2 | Strains having effects of preventing or treating cancers | PDCD1, TOP1, CD274 | CETP 1372/4885SMN1; SMN2 1821/4885NPC1 3432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.